	自己資本および準備金		日付
AbbVie	USD -5.94B	721M	2026-06
Acadia Pharmaceuticals	USD 1.31B	58.54M	2026-06
Agios Pharmaceuticals	USD 1.03B	83.09M	2026-06
ALKERMES	USD 1.81B	57.02M	2026-06
Alnylam Pharmaceuticals	USD 1.35B	278.74M	2026-06
Amgen	USD 11.69B	2.5B	2026-06
Biogen	USD 18.85B	196.3M	2026-06
BioMarin Pharmaceutical	USD 6.32B	109.58M	2026-06
Cytokinetics	USD -173.49M	653.08M	2026-06
Enanta Pharmaceuticals	USD 126.59M	61.87M	2025-12
Exelixis	USD 1.94B	225.57M	2026-03
Gilead Sciences	USD 11.74B	11.77B	2026-06
Halozyme Therapeutics	USD 143.54M	76.09M	2026-06
Incyte	USD 6.34B	721.58M	2026-06
Ionis Pharmaceuticals	USD 439.74M	51.68M	2026-06
Nektar Therapeutics	USD 576.22M	486.38M	2026-03
Neurocrine Biosciences	USD 3.69B	286.2M	2026-06
Pfizer	USD 85.19B	4.91B	2026-06
Prothena	USD 286.89M	25.72M	2026-06
Regeneron Pharmaceuticals	USD 31.71B	287.8M	2026-06
Repligen	USD 2.11B	6.57M	2026-06
Rigel Pharmaceuticals	USD 117.61M	35.67M	2025-09
Sarepta Therapeutics	USD 1.53B	22.7M	2026-06
Teva Pharmaceutical Industries	USD 7.75B	475M	2026-06
Ultragenyx Pharmaceutical	USD -291M	55M	2026-06
Vertex Pharmaceuticals	USD 20.25B	886M	2026-06